Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / Can Bangladesh Build Its Own Diagnostics
Infectious Disease Digital and computational pathology Screening and monitoring Insights Digital Pathology Workforce Trends

Can Bangladesh Build Its Own Diagnostics?

Funding gaps and hidden pathogens challenge health systems, but clear priorities are driving change

By Jessica Allerton 06/23/2026 Discussion 5 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Poll
  • Top Institutions

Share

Can Bangladesh Build Its Own Diagnostics?

Background

Disease surveillance and diagnostic capacity are critical for effective public health responses, especially in low-resource settings like Bangladesh. Despite progress in reducing child mortality, neonatal infections remain a significant challenge, exacerbated by high rates of preterm births and limited understanding of circulating pathogens. Addressing these gaps is essential for improving health outcomes.

Data Highlights

Qualitative insights indicate that funding for disease surveillance programs is declining, and there is a lack of comprehensive understanding of circulating pathogens in low- and middle-income countries.

Key Findings

  • Funding for disease surveillance programs in Bangladesh is declining, impacting diagnostic capacity.
  • There is a lack of comprehensive understanding of circulating pathogens in low- and middle-income countries.
  • Sequencing technology plays a crucial role in pathogen discovery, characterization, and infection control.
  • Neonatal sepsis is a major public health challenge, particularly due to infections from Gram-negative bacteria.
  • Longitudinal studies are needed to track pathogen populations and antimicrobial resistance over time.

Clinical Implications

Healthcare professionals in Bangladesh should focus on enhancing training and infrastructure for disease surveillance, as well as exploring advanced technologies for better understanding of local pathogens.

Conclusion

Strengthening diagnostic services in Bangladesh requires addressing funding and workforce challenges while leveraging technology for improved pathogen detection.

Related Resources & Content

  1. The ASCO Post, 2017 -- Cancer on the Global Stage: Incidence and Cancer-Related Mortality in Bangladesh
  2. International Journal of Infectious Diseases -- AMR in the shadows: The global south and the crisis of diagnostic capacity
  3. Infection -- Pioneering Advances in Tuberculosis Diagnostic Techniques
  4. the pathologist -- ESCMID Global 2026: Faster Diagnostics at What Cost?
  5. Global antibiotic resistance surveillance report 2025
  6. Laboratory testing for dengue virus: interim guidance, April 2025
  7. Global antibiotic resistance surveillance report 2025
  8. Laboratory testing for dengue virus: interim guidance, April 2025
  9. Antibiotic stewardship and point-of-care testing for children in 25 low-income and lower-middle-income countries: a systematic review and meta-analysis - PubMed

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Viral Frontier
Infectious Disease
The Viral Frontier

January 23, 2024

1 min read

The latest on the UK COVID-19 inquiry

What’s New in Infectious Disease? (December 2021)
Infectious Disease
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Infectious Disease
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

Pneumocystis Mysteries
Infectious Disease
Pneumocystis Mysteries

January 21, 2022

1 min read

What is the correct name for this pneumonia-causing pathogen?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.